Bellevue Group’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
|
|||||
|
2024
Q4 | $9.29M | Sell |
|
|||||
|
2024
Q3 | $14.4M | Sell |
|
|||||
|
2024
Q2 | $48.1M | Buy |
|
|||||
|
2024
Q1 | $62.2M | Buy |
|
|||||
|
2023
Q4 | $51.5M | Sell |
|
|||||
|
2023
Q3 | $44.9M | Sell |
|
|||||
|
2023
Q2 | $66.1M | Buy |
|
|||||
|
2023
Q1 | $61M | Buy |
|
|||||
|
2022
Q4 | $63.2M | Buy |
|
|||||
|
2022
Q3 | $51.8M | Buy |
|
|||||
|
2022
Q2 | $49.4M | Buy |
|
|||||
|
2022
Q1 | $35.9M | Buy |
|
|||||
|
2021
Q4 | $24.8M | Buy |
|
|||||
|
2021
Q3 | $26.1M | Sell |
|
|||||
|
2021
Q2 | $65.9M | Sell |
|
|||||
|
2021
Q1 | $54.6M | Buy |
|
|||||
|
2020
Q4 | $35.7M | Sell |
|
|||||
|
2020
Q3 | $79.5M | Sell |
|
|||||
|
2020
Q2 | $63.8M | Buy |
|
|||||
|
2020
Q1 | $41.9M | Buy |
|
|||||
|
2019
Q4 | $43.2M | Buy |
|
|||||
|
2019
Q3 | $1.1M | Buy |
|